Form 8-K - Current report:
SEC Accession No. 0000950170-24-134342
Filing Date
2024-12-09
Accepted
2024-12-09 08:07:20
Documents
12
Period of Report
2024-12-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20241209.htm   iXBRL 8-K 44573
2 EX-99.1 crnx-ex99_1.htm EX-99.1 26187
  Complete submission text file 0000950170-24-134342.txt   188351

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crnx-20241209.xsd EX-101.SCH 23893
14 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20241209_htm.xml XML 4534
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 241533909
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)